Desogestrel

Quick links to important sections

Desogestrel

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Desogestrel

Property Description
Active ingredient Desogestrel
Form Oral tablet
Pharmacological class Progestin / Synthetic Steroid Hormone
Common use Contraception (Pregnancy Prevention)
Origin Synthetic

Desogestrel: Defining its Pharmacological Identity

Desogestrel is a synthetic steroid hormone administered as an oral tablet, classified as a progestin because it functionally mimics the effects of the natural hormone progesterone. It is distinguished as a third-generation progestogen, belonging to a newer group of hormonal agents. Desogestrel exhibits high selectivity and strong binding to the progesterone receptor, which underpins its contraceptive reliability. Upon oral administration, Desogestrel acts as a prodrug; it is rapidly and almost completely metabolized into its biologically active substance, etonogestrel, which is the compound directly responsible for the drug's potent pharmacological effects.

Composition, Form, and General Purpose

The active substance, Desogestrel, is chemically manufactured semi-synthetically, a process that ensures consistent purity. It is principally available in two oral tablet forms: as the sole active ingredient in a Progestogen-Only Pill (POP), offering a viable contraceptive option for women who cannot use estrogen-containing products, or utilized in Combined Oral Contraceptives (COC) alongside an estrogen component. Its general therapeutic purpose is to provide effective contraception and pregnancy prevention. The compound's high potency is a key differentiating factor, making it a choice for long-term use in women of reproductive age seeking a daily oral hormonal contraceptive.

What side effects are possible with Desogestrel?

Possible Side Effects and Safety Information

The safety profile of desogestrel is primarily characterized by hormonal-related effects, particularly concerning the menstrual cycle. Information is drawn from official regulatory documentation for progestogen-only formulations.

Common Adverse Reactions

The most frequently reported side effects (occurring in 1/100 users) include irregular menstruation, amenorrhoea (absence of menstruation), mood changes (including depressed mood), decreased libido, headache, nausea, acne, breast pain, and increased body weight.

Less Common and Rare Reactions

Less common side effects (<1/100, geq 1/1000) may include vaginal infection, contact lens intolerance, vomiting, hair loss (alopecia), dysmenorrhoea (painful menstruation), ovarian cysts, and fatigue. Rare reactions (<1/1000) include skin conditions like rash, urticaria (hives), and erythema nodosum.

Serious Safety Considerations

Serious, though uncommon, safety concerns include the risk of Venous Thromboembolism (VTE), such as deep vein thrombosis and pulmonary embolism. The risk of VTE is generally considered lower than with combined hormonal contraceptives, but this remains a significant safety note. Ectopic pregnancy must also be considered in the event of persistent amenorrhoea or abdominal pain. Hypersensitivity reactions, including angioedema and anaphylaxis, have been reported at an unknown frequency.

Safety Restrictions and Contraindications

Desogestrel is strictly contraindicated in women with an active venous thromboembolic disorder, current or history of severe hepatic disease (until liver function normalizes), known or suspected sex-steroid sensitive malignancies (e.g., breast cancer), and undiagnosed vaginal bleeding. Users with a history of chloasma (patches of skin hyperpigmentation) are advised to avoid sun or ultraviolet radiation exposure. Special caution is also warranted in cases of severe hypertension or prolonged immobilization.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Desogestrel (a progestin-only medication) indicates that an acute overdosage is generally associated with a low risk of serious harm. Regulatory bodies report that no severe or life-threatening toxicities have been confirmed following an acute overdose.


Documented Overdose Manifestations

The following non-serious effects are the clinical signs most consistently reported in government-authorized prescribing information:

  • Nausea and Vomiting
  • Vaginal Bleeding or withdrawal bleeding, which may occur in females of all ages, including young girls.

Emergency Actions and Management

No specific antidote exists for Desogestrel overdosage. The official management approach is symptomatic treatment and supportive care. If a significant overdose is suspected, contact a Poison Control Center or a healthcare provider for case-specific guidance.

Urgent medical attention is not typically necessitated by the direct pharmacological effects of Desogestrel overdosage, as documented effects are non-serious. However, medical help should be sought if an individual experiences acute, concerning symptoms or if the expected manifestations of nausea and vomiting are severe or persistent.

Therapeutic Uses of Desogestrel

What Desogestrel Treats: Main Uses and Benefits

Desogestrel is used in situations involving certain distressing symptoms and applied across domains where additional symptomatic support is needed in women's reproductive health. This medication is commonly used to help with pregnancy prevention and the management of specific gynecological symptoms.

Supporting Reproductive Control and Symptom Management

The medication primarily supports therapeutic benefit in three key areas: supporting reliable contraception, is applied in addressing symptom clusters related to heavy and painful menstruation, and providing symptom support for underlying gynecological conditions. It is considered a relevant option for estrogen-intolerant patients and is applied in the specific clinical scenario of providing a progestogen-only method for breastfeeding women. Desogestrel is commonly used to help with conditions presenting with systemic or localized discomfort, particularly Heavy Menstrual Bleeding (Menorrhagia), painful cramping (Dysmenorrhea), and may assist with managing symptoms linked to Endometriosis and Uterine Fibroids.

“It may assist with maintaining a sense of control and confidence in long-term family planning, and contributes to improved comfort during symptomatic periods.”

This therapeutic focus on symptom clusters that interfere with daily functioning generally contributes to easing the overall symptom load on a patient's routine stability.

Quick Fact: Symptom Support
Desogestrel may be part of symptomatic management to help moderate symptom clusters that may become intense or disruptive, such as easing the distress associated with heavy blood loss and menstrual pain.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Desogestrel?

The eligibility for Desogestrel (as a progestogen-only pill) is strictly defined by regulatory documents, focusing on conditions that pose a severe health risk if the medicine is used. Individuals who must not use Desogestrel fall into specific contraindicated categories:

  • Active Venous Thromboembolic Disorder: A history of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) is an absolute exclusion.
  • Malignancy: Known or suspected sex-steroid sensitive malignancies, such as certain breast cancers, prohibit use.
  • Hepatic Issues: Presence or history of severe hepatic disease or hepatic tumours disqualifies use until liver function has normalized.
  • Pregnancy: The medication is contraindicated during pregnancy.
  • Bleeding: The presence of undiagnosed abnormal genital bleeding prevents eligibility.

Special Populations

Use is generally allowed during breastfeeding/lactation, although small amounts of the active metabolite are excreted in breast milk. The safety and efficacy in adolescents below 18 years are often listed as not established in official labeling, and the medication is not indicated for the geriatric population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define Desogestrel's interaction profile based on pharmacokinetic and pharmacodynamic outcomes.

Formal Contraindications and Restrictions

Co-administration with the Hepatitis C combination regimen of Ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, is formally contraindicated due to the risk of liver enzyme elevations. A procedural constraint requires Desogestrel to be discontinued prior to initiating this regimen and to be restarted approximately 2 weeks following completion.

Metabolic and Exposure Alterations

The simultaneous use of certain medicinal products is documented to alter the systemic exposure of Desogestrel's active metabolite (etonogestrel). Enzyme-inducing substances, which include antiepileptic medicines like Phenytoin and Carbamazepine, are documented to reduce circulating levels, an effect also associated with the herbal product St. John's Wort. Conversely, strong CYP3A4 inhibitors such as Itraconazole and Ketoconazole are documented to increase the plasma concentration.

Desogestrel may also interfere with the metabolism of co-administered drugs, leading to increased plasma levels of Ciclosporine or decreased plasma levels of Lamotrigine.

Other Documented Interactions

The combination with Tranexamic Acid is associated with a documented additive risk for thromboembolic events. A population-specific constraint notes that patients with impaired liver function face a risk of altered clearance and increased systemic exposure of the active metabolite.

Mechanism of Action

How Desogestrel Works (Mechanism of Action)

Desogestrel functions through its active metabolite, etonogestrel, which is responsible for the pharmacodynamic activity. This mechanism involves two principal domains of action.

Suppression of the Central HPO Axis

Etonogestrel acts as an agonist at progesterone receptors (PR) within the central nervous system, specifically in the hypothalamus and the pituitary gland. This interaction initiates a negative feedback loop that modulates the release of Luteinizing Hormone (LH). The resulting suppression prevents the required LH surge necessary for follicular rupture. This suppression of the hypothalamic-pituitary-ovarian (HPO) axis culminates in the primary mechanistic outcome of inhibition of ovulation (anovulation).

Alteration of Peripheral Reproductive Morphology

Additionally, etonogestrel exerts a direct peripheral effect by binding to local PR in the cervical glandular tissue and the endometrium. In the cervix, this binding modifies secretory activity, resulting in the production of viscous cervical mucus that impedes sperm motility and penetration. Concurrently, its action on the endometrium leads to a thin, atrophic endometrial lining.

Dosage and Administration Information

How to Use Desogestrel

Desogestrel is administered exclusively via the oral route as a tablet. Its use is defined by distinct schedules: either as a Progestogen-Only Pill (POP) containing 75 mu g desogestrel or as part of a Combined Oral Contraceptive (COC) in conjunction with ethinyl estradiol.


Administration Protocol

The standard protocol requires taking one tablet daily (qDay) at approximately the same time each day to ensure a consistent 24-hour dosing interval. The tablets can be swallowed whole with a small amount of liquid, and administration is acceptable with or without food.


Schedule and Timing Constraints

Usage patterns differ by formulation. The 75 mu g POP requires continuous tablet-taking, meaning a new pack is started immediately after completing the current one, without a hormone-free interval. The COC formulation typically involves a cyclic 28-day regimen, which includes seven days of non-hormonal or placebo tablets. Postpubertal adolescents use the same dosing regimen as adults.

Handling of Missed Doses

Standard procedures exist for delayed doses. For the POP, if tablet-taking is delayed by more than 12 hours from the scheduled time, the missed tablet is taken immediately, and additional non-hormonal barrier protection is required for the following 7 days of uninterrupted tablet-taking. If vomiting occurs within 3 to 4 hours of administration, the protocol for a missed tablet is followed.

Recent Clinical Evidence

Desogestrel: Recent Clinical Evidence

Recent clinical research on desogestrel, a synthetic progestogen, primarily focuses on its use as a progestogen-only contraceptive and its potential applications in gynecological conditions.

Contraceptive Efficacy

Clinical trials have evaluated the efficacy of the 75 microgram desogestrel-only pill. Research found that this formulation led to a significantly higher mathbfinhibition mathbfof mathbfovulation compared to traditional levonorgestrel-only pills in study cycles, suppressing ovulation in approximately 97% of cycles examined. However, comparative studies of overall failure rates (Pearl indices) between the desogestrel-only pill and other progestogen-only pills have not shown a statistically significant difference in contraceptive effectiveness.

Bleeding Profile and Acceptability

Studies examining the bleeding pattern found that users of the desogestrel-only pill often experienced a mathbfvariable mathbfpattern of bleeding, which was noted to be more common initially than with levonorgestrel-only pills. With continued use over 11–13 months, studies indicated that nearly 50% of desogestrel users reported infrequent bleeding or amenorrhoea (absence of menstrual bleeding).

Non-Contraceptive Indications

Desogestrel is also being investigated for therapeutic uses beyond contraception. Ongoing and completed randomized controlled trials have examined the use of desogestrel for the mathbfpreoperative mathbftreatment mathbfof mathbfendometriomas (cysts related to endometriosis), assessing its effects on cyst diameter and associated pain. Other areas of research have explored its role in managing problematic bleeding while using contraceptive implants and its effects in women with endometriosis and related pelvic pain.

Frequently Asked Questions (FAQ)

Common questions about Desogestrel (FAQ)


Q: How quickly does Desogestrel start working to prevent pregnancy?

A: If pill-taking is started on the first day of the period, official product information states that no additional contraceptive protection is needed. However, if starting on days 2 through 5 of the cycle, a non-hormonal barrier method, such as a condom, is required for the first seven days of uninterrupted pill-taking.


Q: What happens if I miss a Desogestrel pill—what's the 'grace period'?

A: According to regulatory instructions, if a tablet is missed by less than 12 hours, contraceptive protection is maintained, and it is recommended to take the missed tablet right away. If the delay is more than 12 hours, it is recommended that the missed tablet be taken immediately, and that a barrier method also be used for the next seven days of continuous pill-taking.


Q: Can you take Desogestrel while breastfeeding?

A: Regulatory documents indicate that Desogestrel can be used during breastfeeding. While a small amount of the active metabolite does pass into the breast milk, studies show no evidence of risk to the health, growth, or development of the infant.


Q: Does Desogestrel cause weight gain or changes in appetite?

A: Increased body weight is listed as a common side effect in regulatory documents and patient information leaflets. However, specific changes in appetite are not explicitly listed as a common or uncommon adverse reaction.


Q: Can Desogestrel affect your mood or cause anxiety?

A: Official product information lists mood changes, including depressed mood, and decreased libido (sexual desire) as common side effects. Anxiety itself is not typically listed as a distinct, common side effect in regulatory documents.


Q: What is the difference between Desogestrel and Levonorgestrel mini-pill?

A: One difference relates to their effect on ovulation suppression. Clinical studies have shown that the active metabolite of Desogestrel provides a significantly higher rate of ovulation inhibition compared to the progestogen Levonorgestrel. However, overall long-term failure rates are generally not considered significantly different between the two types of mini-pills.


Q: Does Desogestrel have a known interaction with common antibiotics?

A: Official information explicitly warns that enzyme-inducing substances (a group that includes some medicines for epilepsy) can reduce the effectiveness of Desogestrel. Always review all medicines with a healthcare professional to check for potential drug interactions, even if a specific antibiotic is not listed.


Q: Is it safe to take Desogestrel if I have a history of migraines?

A: Headache is listed as a common side effect. Regulatory warnings specify that the medication should be discontinued if a migraine with focal neurological symptoms develops or worsens. Caution is advised if there is a history of severe headaches or migraines.


Q: Is it safe to take Desogestrel long-term, over several years?

A: Regulatory documents address specific safety considerations for long-term use, such as the risks of certain cancers and blood clots (VTE). Long-term use is subject to periodic benefit/risk reassessment by a healthcare professional, as described in official guidelines.


Q: Does Desogestrel help with acne or cause breakouts?

A: Acne is listed as a common adverse reaction in official safety information. The fact that acne is listed as an adverse reaction indicates that the medicine may be associated with causing or worsening breakouts.


Q: Does Desogestrel affect libido or sexual desire?

A: Yes, official safety information lists decreased libido (sexual desire) as a common side effect of taking Desogestrel.


Q: Do other medicines for epilepsy or seizures affect Desogestrel's function?

A: Yes, many antiepileptic medicines are known as enzyme-inducing substances. Regulatory documents confirm that specific medicines like Phenytoin and Carbamazepine can reduce the circulating levels of Desogestrel’s active metabolite, which can potentially reduce its contraceptive effectiveness.


Q: Can Desogestrel cause water retention or bloating?

A: Official documentation lists increased body weight as a common side effect. However, water retention or bloating is not explicitly named as a distinct common or uncommon side effect in the regulatory information.


Q: Is it normal to feel nauseous when you first start Desogestrel?

A: Nausea is listed as a common side effect of Desogestrel. As with many medications, common side effects are frequently reported when treatment is first started.


Q: What happens if I start taking Desogestrel later than the first day of my period?

A: If you start the pill pack between day 2 and day 5 of your period, official guidance recommends the use of an additional non-hormonal barrier method of contraception for the first seven days of continuous pill-taking to ensure protection.


Q: Are there special considerations for people with diabetes taking Desogestrel?

A: Regulatory guidance indicates that patients with diabetes are recommended to be closely monitored during the use of Desogestrel. This is especially important if the diabetes includes vascular (blood vessel) symptoms.


Q: Does Desogestrel impact bone density over time?

A: Treatment with Desogestrel results in decreased estrogen (estradiol) serum levels. Regulatory documents note this decrease but state it is currently unknown whether this has any clinically relevant negative effect on bone mineral density over the long term.


Q: Does taking Desogestrel impact the results of common lab tests?

A: Yes, the medication may interfere with the results of certain laboratory tests. This includes tests that measure parameters of liver, thyroid, adrenal, and renal function, as well as those that measure plasma levels of certain binding proteins.


Q: How long does it take for Desogestrel's side effects to typically lessen?

A: While regulatory documents do not provide a fixed timeline for all side effects, they note that irregular bleeding, one of the most common issues, often improves or resolves with continued use over several months.


Q: Is there a maximum age limit for using Desogestrel?

A: Official documents state that the medication is not indicated for the geriatric population (typically defined as over 65). While there is no explicit maximum age limit for women of reproductive age, individual risk factors are assessed by a healthcare professional.


Q: Are there any dietary restrictions while taking Desogestrel?

A: No specific dietary restrictions are noted in the product information. The tablets can be taken either with or without food.


Q: What are the reasons someone would be advised to stop taking Desogestrel?

A: Regulatory information lists specific reasons for discontinuation. These include the development of an active venous thromboembolic disorder (blood clot), the onset of a severe, sustained high blood pressure that is unresponsive to treatment, or prolonged immobilization due to illness or surgery.


Q: What have clinical studies shown about the effectiveness rate of Desogestrel?

A: Clinical trials have shown that Desogestrel suppresses ovulation in approximately 97% of study cycles, a significantly higher rate than some older progestogen-only pills. Overall failure rates (Pearl indices), however, are not reported as statistically different from other progestogen-only pills.


Q: What is the role of the synthetic progestogen in Desogestrel?

A: Desogestrel is a synthetic progestogen that acts as a prodrug, meaning it must be metabolized into its active form, etonogestrel. This active metabolite suppresses the release of Luteinizing Hormone (LH) to prevent ovulation and also changes the cervical mucus and the uterine lining.


Q: How does Desogestrel affect the cervical mucus barrier?

A: The active metabolite of Desogestrel works by modifying the tissue of the cervix. This causes the production of a thicker, more viscous cervical mucus that acts as a physical barrier, making it difficult for sperm to move and penetrate.


Q: Why is Desogestrel a popular choice for some people over other birth control pills?

A: A primary advantage noted in regulatory documents is that Desogestrel is a progestogen-only method. This makes it a suitable contraceptive option for women who have contraindications or sensitivities to estrogen-containing contraceptives (combined pills).

How should Desogestrel be stored and disposed of?

How to Store and Dispose of Desogestrel

Desogestrel tablets require specific handling to maintain stability and ensure safety, as documented in official regulatory labeling.

Storage Requirements

Condition Requirement
Temperature Do not store above 30 C.
Protection Must be kept protected from light and moisture in the original sachet.
Stability Has an in-use period of one month after the original sachet is first opened.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired desogestrel must be disposed of according to local requirements. It must not be thrown away via wastewater or household waste. The active metabolite, etonogestrel, is classified as an environmental risk, requiring controlled disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Desogestrel found in:

A-Z Index: